Immunotherapy with CD19ζ gene-modified EBV-specific CTLs after stem cell transplant in children with high-risk acute lymphoblastic leukemia (CD 19)

Basic data for this project

Type of projectOwn resources project
Duration at the University of Münster01/01/2007 - 31/12/2007

Description

KeywordsAcute Lymphoblastic Leukemia

Project management at the University of Münster

Rössig, Claudia
University Children's Hospital - Department of Paediatric Haematology and Oncology (UKM PHO)

Research associates from the University of Münster

Gerß, Joachim
Institute of Biostatistics and Clinical Research (IBKF)